COTD: Singapore startup funding jumps 46.72% MoM in March

Early-stage startups (94.3%) held the largest share of funding.

Singapore's startup funding jumped by 46.72% month-on-month to $80.4m in March, Tracxn reported.

Year-on-year, funding sank by 81.24%.

Early-stage startups (94.3%) held the largest share of funding in March, followed by seed-stage ventures (5.7%).

Chitose Bio Evolution ($49m), AMP ($12.6m), RockFlow ($10m), Agros ($4.3m), and MitoHealth ($2.2m) were the top deals for the month.

In March, Iterative led the venture capital funding, also emerging as the top incubator.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia